Sarmal, Inc. is a genomics company developing next generation innovations in sequencing and advanced target sequence detection
FLASH Sequencing
A single molecule, DNA sequencing technology that, for the first time, can achieve unlimited read lengths. This technology transforms the the field of genomics by achieving whole genome sequencing with a cost of well under $100 dollars per genome using low-cost devices, and game-changing low error rates.
DeTaiL Platform
A portable, field deployable nucleic acid based diagnostic platform, that will that achieve cost-effective gold-standard specificity and sensitivity in five minutes - sample-to-answer. This makes possible the profound goal of screening large population a reality.
Company Details
- Employees
- 7
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sarmal.com
Sarmal, Inc. Questions
Sarmal, Inc.'s website is http://www.sarmal.com
Sarmal, Inc.'s LinkedIn profile is https://www.linkedin.com/company/sarmal-inc
Sarmal, Inc. has
7 employees.
View email and phone details for 7
employees at Sarmal, Inc..
Sarmal, Inc.'s industry is
Biotechnology Research
Sarmal, Inc.'s top competitors are
Neurocrine Biosciences,
Lokum Games,
Semiconbio Inc.,
Catalent,
Bps Bioscience Inc.,
Zen Neuroscience,
Exact Sciences,
Truvian,
Bash Biotech Inc.,
Innovasion Labs Pinc, Inc..
Sarmal, Inc.'s categories are Biotechnology Research
